Could stem cells from umbilical cords help stroke patients recover?
NCT ID NCT06129175
First seen Jan 05, 2026
Summary
This study tests whether infusions of stem cells from umbilical cords (Neuroncell-EX) can help people recover after a moderate to severe stroke. Eighty adults who had a stroke within the last 4 weeks and cannot receive standard clot-busting treatment will receive either the stem cells or a placebo. The main goal is to see if the treatment improves daily functioning and reduces disability over one year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Canselor Tuanku Muhriz UKM
RECRUITINGCheras, Kuala Lumpur, 56000, Malaysia
Contact
Contact
Contact
Contact
Contact Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
umbilical cord mesenchymal stem cells (Neuroncell-EX)
What this could lead to
If it works, this could lead to a new treatment that improves recovery and reduces disability after a stroke.
What could go wrong
This is an early combined phase 2-3 trial with only 80 participants, so results may not be conclusive. Stem cell treatments can have unknown side effects, and the therapy may not improve outcomes more than standard care.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.